The Pharmacy Defense Fund supports the FTC's proposed study of generic drug competition
MLex Summary: The Pharmacy Defense Fund supports the US Federal Trade Commission's proposed study of generic drug competition saying that innovators of new drug entities are entitled to every minute of...To view the full article, register now.
Already a subscriber? Click here to view full article